References
- Beaumont M, Sanz M, Carli PM, et al Therapy-related acute promyelocytic leukemia. J Clin Oncol 2003;21:2123–2137.
- Pulsoni A, Pagano L, Lo Coco F, et al Clinicobiological features and outcome of acute promyelocytic leukemia occurring as a second tumor: the GIMEMA experience. Blood 2002;100:1972–1976.
- Wang ZY, Chen Z. Acute promyelocytic leukemia: from highly fatal to highly curable. Blood 2008;111:2505–2515.
- Mathews V, George B, Lakshmi KM, et al Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity. Blood 2006;107:2627–2632.
- Shen ZX, Shi ZZ, Fang J, et al All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia. Proc Natl Acad Sci USA 2004;101:5328–5335.
- Estey E, Garcia-Manero G, Ferrajoli A, et al Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia. Blood 2006;107:3469–3473.
- Hu J, Liu YF, Wu CF, et al Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia. Proc Natl Acad Sci USA 2009;106:3342–3347.
- Ravandi F. Therapy-related acute promyelocytic leukemia: further insights into the molecular basis of the disease and showing the way forward in therapy. Leuk Lymphoma 2009;50:1073–1074.
- Mistry AR, Felix CA, Whitmarsh RJ, et al DNA topoisomerase II in therapy-related acute promyelocytic leukemia. N Engl J Med 2005;352:1529–1538.
- Mays AN, Osheroff N, Xiao Y, et al Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t(15;17) therapy-related acute promyelocytic leukemia. Blood 2010;115:326–330.
- Hasan SK, Mays AN, Ottone T, et al Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosis. Blood 2008;112:3383–3390.
- Sanz MA, Grimwade D, Tallman MS, et al Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood 2009;113:1875–1891.